We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$69.4B
AUM Growth
-$5.97B
Cap. Flow
-$8.1B
Cap. Flow %
-11.68%
Top 10 Hldgs %
11.91%
Holding
4,468
New
542
Increased
1,601
Reduced
1,691
Closed
599

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.03B
2
UNH icon
UnitedHealth
UNH
+$686M
3
TSLA icon
Tesla
TSLA
+$387M
4
ABT icon
Abbott
ABT
+$380M
5
CVX icon
Chevron
CVX
+$328M

Sector Composition

Rank Sector Weight
1 Technology 20.26%
2 Healthcare 16.96%
3 Consumer Discretionary 12.82%
4 Consumer Staples 9.14%
5 Industrials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCNX
3801
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$16K ﹤0.01%
+220
New +$18.3K
NEXI
3802
DELISTED
NexImmune, Inc. Common Stock
NEXI
$16K ﹤0.01%
2,264
+688
+44% +$5.93K
NDRA icon
3803
ENDRA Life Sciences
NDRA
$5.64M
$15K ﹤0.01%
+6
New +$16.9K
HPCO
3804
DELISTED
Hempacco Co., Inc. Common Stock
HPCO
$15K ﹤0.01%
3,920
+1,510
+63% +$8.4K
SONX
3805
DELISTED
Sonendo, Inc.
SONX
$15K ﹤0.01%
11,200
-2,900
-21% -$3.94K
ENTX icon
3806
Entera Bio
ENTX
$147M
$14K ﹤0.01%
16,100
+5,700
+55% +$4.87K
ITP icon
3807
IT Tech Packaging
ITP
$2.94M
$14K ﹤0.01%
29,818
+800
+3% +$367
TAOX
3808
Tao Synergies Inc
TAOX
$25.2M
$14K ﹤0.01%
616
+76
+14% +$1.66K
XWEL icon
3809
XWELL
XWEL
$8.7M
$14K ﹤0.01%
3,565
+180
+5% +$936
AIH
3810
DELISTED
Aesthetic Medical International Holdings
AIH
$14K ﹤0.01%
13,000
-300
-2% -$317
BTTX
3811
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$14K ﹤0.01%
+13,400
New +$13K
AUID icon
3812
authID Inc
AUID
$11.3M
$13K ﹤0.01%
+1,850
New +$7.92K
BJDX icon
3813
Bluejay Diagnostics
BJDX
$918K
$13K ﹤0.01%
2
+1
+100% +$9.04K
BYSI icon
3814
BeyondSpring
BYSI
$48.1M
$13K ﹤0.01%
10,776
-111,595
-91% -$125K
NVVE
3815
DELISTED
Nuvve Holding Corp
NVVE
0
PIK
3816
DELISTED
Kidpik Corp. Common Stock
PIK
$13K ﹤0.01%
+3,200
New +$10.4K
EBET
3817
DELISTED
EBET, INC. Common Stock
EBET
$13K ﹤0.01%
3,717
+487
+15% +$4.02K
LGL.WS
3818
DELISTED
LGL Group Inc Warrants
LGL.WS
$12K ﹤0.01%
81,964
-9,095
-10% -$1.36K
MWG icon
3819
Multi Ways Holdings
MWG
$6.02M
$12K ﹤0.01%
+2,050
New +$52.9K
LYT
3820
DELISTED
Lytus Technologies Holdings PTV. Ltd. Common Shares
LYT
$12K ﹤0.01%
422
-128
-23% -$4.67K
NYMX
3821
DELISTED
Nymox Pharmaceutical Corp
NYMX
$12K ﹤0.01%
60,800
-8,581
-12% -$3.38K
ZOM
3822
DELISTED
Zomedica Corp.
ZOM
$12K ﹤0.01%
+58,822
New +$11.9K
ABTS icon
3823
Abits Group
ABTS
$3.2M
$11K ﹤0.01%
787
-460
-37% -$6.42K
PYPD icon
3824
PolyPid
PYPD
$81.3M
$11K ﹤0.01%
+960
New +$11.5K
SLNH icon
3825
Soluna Holdings
SLNH
$200M
$11K ﹤0.01%
+2,072
New +$10.9K

Similar funds

Renaissance Technologies's Q2 2023 Portfolio in Review

As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.

  • Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
  • Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
  • Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
  • Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
  • Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
  • Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
  • Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.